Processa Pharma Stock (NASDAQ: PCSA) stock price, news, charts, stock research, profile.
Open | $2.110 |
Close | $2.090 |
Volume / Avg. | 56.712K / 1.468M |
Day Range | 2.080 - 2.190 |
52 Wk Range | 1.400 - 18.000 |
Market Cap | $5.973M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 7.37% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Processa Pharma (NASDAQ: PCSA) through any online brokerage.
Other companies in Processa Pharma’s space includes: Cingulate (NASDAQ:CING), Kiora Pharmaceuticals (NASDAQ:KPRX), Universe Pharmaceuticals (NASDAQ:UPC), Akanda (NASDAQ:AKAN) and Palisade Bio (NASDAQ:PALI).
The latest price target for Processa Pharma (NASDAQ: PCSA) was reported by HC Wainwright & Co. on Thursday, April 25, 2024. The analyst firm set a price target for 8.00 expecting PCSA to rise to within 12 months (a possible 282.78% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Processa Pharma (NASDAQ: PCSA) is $2.09 last updated May 10, 2024 at 6:26 PM EDT.
There are no upcoming dividends for Processa Pharma.
Processa Pharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Processa Pharma.
Processa Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.